Literature DB >> 1894374

Purification and characterization of the heat-labile toxin of Bordetella pertussis.

Y L Zhang1, R D Sekura.   

Abstract

A procedure is described for purification of pertussis heat-labile toxin (PEHLT) from cells of Bordetella pertussis. The purification procedure, performed in the cold and in the presence of protease inhibitors, gives 1,350-fold purification with yields of about 60%. The toxin was shown to be a single-chain polypeptide of 140 kDa, pI 6.02. It was completely inactivated by heating at 56 degrees C for 60 min. Rabbit antiserum prepared against PEHLT neutralized the toxin and gave a single precipitin line on immunodiffusion. In immunodiffusion assays, this anti-PEHLT serum did not react with pertussis toxin, filamentous hemagglutinin, or preparations of pertussis adenylate cyclase. Purified PEHLT elicited dermonecrosis and atrophy of the spleen. PEHLT is extraordinarily active; 0.4 X 10(-12) g caused necrotic lesions in newborn mice, and with 18- to 20-g mice the 50% lethal dose was about 11 X 10(-9) g.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894374      PMCID: PMC258947          DOI: 10.1128/iai.59.10.3754-3759.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  CHEMICAL STUDIES ON CELLULAR COMPONENTS OF BORDETELLA PERTUSSIS. III. ISOLATION OF HIGHLY POTENT TOXIN FROM BORDETELLA PERTUSSIS.

Authors:  K ONOUE; M KITAGAWA; Y YAMAMURA
Journal:  J Bacteriol       Date:  1963-10       Impact factor: 3.490

2.  Antigens of Bordetella pertussis. II. Purification of heat-labile toxin.

Authors:  A BANERJEA; J MUNOZ
Journal:  J Bacteriol       Date:  1962-08       Impact factor: 3.490

3.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

4.  Intracellular localization of the dermonecrotic toxin of Bordetella pertussis.

Authors:  J L Cowell; E L Hewlett; C R Manclark
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

5.  Separation of pertussal toxin.

Authors:  K C ROBBINS; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1950-05

6.  A highly sensitive adenylate cyclase assay.

Authors:  Y Salomon; C Londos; M Rodbell
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

7.  Protein assay for dilute solutions.

Authors:  E Cabib; I Polacheck
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

8.  Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase.

Authors:  R D Sekura; F Fish; C R Manclark; B Meade; Y L Zhang
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

9.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein.

Authors:  G M Bokoch; T Katada; J K Northup; E L Hewlett; A G Gilman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

10.  Production and properties of Bordetella pertussis heat-labile toxin.

Authors:  I Livey; A C Wardlaw
Journal:  J Med Microbiol       Date:  1984-02       Impact factor: 2.472

View more
  4 in total

1.  Uptake and intracellular survival of Bordetella pertussis in human macrophages.

Authors:  R L Friedman; K Nordensson; L Wilson; E T Akporiaye; D E Yocum
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp.

Authors:  G D Pullinger; T E Adams; P B Mullan; T I Garrod; A J Lax
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Characterization of the dermonecrotic toxin in members of the genus Bordetella.

Authors:  K E Walker; A A Weiss
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.